[Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure : Short version of the S3 guideline].

Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen : Kurzversion der AWMF-S3-Leitlinie.

Extracorporeal Circulation Extracorporeal Membrane Oxygenation Germany Humans Life Support Systems Shock

Association of the Scientific Medical Societies in Germany Cardiac failure Cardiomyopathy ECC ECLS Mechanical circulatory support

Journal

Der Anaesthesist

ISSN: 1432-055X

Titre abrégé: Anaesthesist

Pays: Germany

ID NLM: 0370525

Informations de publication

Date de publication:
11 2021

Historique:

pubmed: 20 10 2021

medline: 25 11 2021

entrez: 19 10 2021

Statut: ppublish

Résumé

In Germany, a remarkable increase regarding the usage of extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) systems has been observed in recent years with approximately 3000 ECLS/ECMO implantations annually since 2015. Despite the widespread use of ECLS/ECMO, evidence-based recommendations or guidelines are still lacking regarding indications, contraindications, limitations and management of ECMO/ECLS patients. Therefore in 2015, the German Society of Thoracic and Cardiovascular Surgery (GSTCVS) registered the multidisciplinary S3 guideline "Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure" to develop evidence-based recommendations for ECMO/ECLS systems according to the requirements of the Association of the Scientific Medical Societies in Germany (AWMF). Although the clinical application of ECMO/ECLS represents the main focus, the presented guideline also addresses structural and economic issues. Experts from 17 German, Austrian and Swiss scientific societies and a patients' organization, guided by the GSTCVS, completed the project in February 2021. In this report, we present a summary of the methodological concept and tables displaying the recommendations for each chapter of the guideline. Seit einigen Jahren ist eine stetige Zunahme des Einsatzes von mechanischen extrakorporalen Herz-Kreislauf- und Lungenunterstützungssystemen (ECLS/ECMO) zu verzeichnen. So wurden seit 2015 in Deutschland jährlich bei etwa 3000 Patienten ECLS/ECMO-Systeme implantiert. Trotz dieser häufigen Anwendung der passageren Unterstützungssysteme existieren zurzeit national und international nur Leitlinien zum Einsatz der ECMO/ECLS, die erkrankungsbezogene Teilaspekte komplexer Therapiekaskaden adressieren. Vor diesem Hintergrund erschien es notwendig, evidenzbasierte Empfehlungen zur ECLS/ECMO-Therapie im Hinblick auf Indikationen und das komplexe Patientenmanagement zu verfassen, in denen personelle, prozessuale und infrastrukturelle Anforderungen definiert werden. Aus diesem Grund erfolgte im Juli 2015 durch die Deutsche Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG) die Anmeldung einer diesbezüglichen S3-Leitlinie bei der zuständigen Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF). Im Mittelpunkt der Leitlinie steht die klinische Anwendung der ECLS/ECMO-Therapie; ergänzend werden auch strukturelle und ökonomische Aspekte adressiert. Unter Federführung der DGTHG wurde mit Einbindung von Experten aus Deutschland, Österreich und der Schweiz, delegiert aus 11 AWMF-Fachgesellschaften, 5 weiteren Fachgesellschaften sowie der Patientenvertretung, die S3-Leitlinie im Februar 2021 publiziert. Dieser Artikel stellt eine kurze Zusammenfassung des methodischen Konzepts sowie aller konsentierten Empfehlungen für jede bearbeitete Fragestellung der Leitlinie dar.

Autres résumés

Type: Publisher (ger)

Seit einigen Jahren ist eine stetige Zunahme des Einsatzes von mechanischen extrakorporalen Herz-Kreislauf- und Lungenunterstützungssystemen (ECLS/ECMO) zu verzeichnen. So wurden seit 2015 in Deutschland jährlich bei etwa 3000 Patienten ECLS/ECMO-Systeme implantiert. Trotz dieser häufigen Anwendung der passageren Unterstützungssysteme existieren zurzeit national und international nur Leitlinien zum Einsatz der ECMO/ECLS, die erkrankungsbezogene Teilaspekte komplexer Therapiekaskaden adressieren. Vor diesem Hintergrund erschien es notwendig, evidenzbasierte Empfehlungen zur ECLS/ECMO-Therapie im Hinblick auf Indikationen und das komplexe Patientenmanagement zu verfassen, in denen personelle, prozessuale und infrastrukturelle Anforderungen definiert werden. Aus diesem Grund erfolgte im Juli 2015 durch die Deutsche Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG) die Anmeldung einer diesbezüglichen S3-Leitlinie bei der zuständigen Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF). Im Mittelpunkt der Leitlinie steht die klinische Anwendung der ECLS/ECMO-Therapie; ergänzend werden auch strukturelle und ökonomische Aspekte adressiert. Unter Federführung der DGTHG wurde mit Einbindung von Experten aus Deutschland, Österreich und der Schweiz, delegiert aus 11 AWMF-Fachgesellschaften, 5 weiteren Fachgesellschaften sowie der Patientenvertretung, die S3-Leitlinie im Februar 2021 publiziert. Dieser Artikel stellt eine kurze Zusammenfassung des methodischen Konzepts sowie aller konsentierten Empfehlungen für jede bearbeitete Fragestellung der Leitlinie dar.

Identifiants

DOI: 10.1007/s00101-021-01058-8 PMID: 34665266

pubmed: 34665266

doi: 10.1007/s00101-021-01058-8

pii: 10.1007/s00101-021-01058-8

doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

Pagination

942-950

Informations de copyright

Références

Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Muller T, Windisch W (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42(5):889–896

pubmed: 26942446 doi: 10.1007/s00134-016-4273-z

Beckmann A, Meyer R, Lewandowski J, Markewitz A, Gummert J (2021) German heart surgery report 2020: the annual updated registry of the German society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg 69(4):294–307

pubmed: 34176107 doi: 10.1055/s-0041-1730374

Assmann A, Boeken U, Klotz S, Harringer W, Beckmann A (2019) Organization and application of ECLS therapy‑A nationwide survey in German cardiosurgical departments. Thorac Cardiovasc Surg 67(3):164–169. https://doi.org/10.1055/s-0038-1675597

doi: 10.1055/s-0038-1675597 pubmed: 30458568

(2020) Extrakorporale Zirkulation (ECLS / ECMO), Einsatz bei Herz- und Kreislaufversagen. S3-Leitlinie. AWMF-RN 011-021. https://www.awmf.org/leitlinien/detail/ll/011-021.html . Zugegriffen: 25. Aug. 2021

Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406

pubmed: 21208779 doi: 10.1016/j.jclinepi.2010.07.015

Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, Brozek J, Vist G, Rind D, Akl EA, Schunemann HJ (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66(7):719–725

doi: 10.1016/j.jclinepi.2012.03.013

Michels G, Wengenmayer T, Hagl C, Dohmen C, Bottiger BW, Bauersachs J, Markewitz A, Bauer A, Grasner JT, Pfister R, Ghanem A, Busch HJ, Kreimeier U, Beckmann A, Fischer M, Kill C, Janssens U, Kluge S, Born F, Hoffmeister HM, Preusch M, Boeken U, Riessen R, Thiele H (2019) Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC. Clin Res Cardiol 108(5):455–464

pubmed: 30361819 doi: 10.1007/s00392-018-1366-4

Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstrom AE, Lagrand WK, Cherpanath TGV, Driessen AHG, de Mol B, Henriques JPS (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42(12):1922–1934

pubmed: 27647331 pmcid: 5106498 doi: 10.1007/s00134-016-4536-8

Chen SW, Tsai FC, Lin YS, Chang CH, Chen DY, Chou AH, Chen TH (2017) Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock. J Thorac Cardiovasc Surg 154(2):469–477e2

pubmed: 28413074 doi: 10.1016/j.jtcvs.2017.02.055

Chang JJ, Lin MS, Chen TH, Chen DY, Chen SW, Hsu JT, Wang PC, Lin YS (2017) Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment—a nationwide cohort study. Int J Med Sci 14(12):1241–1250

pubmed: 29104480 pmcid: 5666557 doi: 10.7150/ijms.20618

Schiller P, Hellgren L, Vikholm P (2019) Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score. Eur Heart J Acute Cardiovasc Care 8(4):329–337

pubmed: 30406678 doi: 10.1177/2048872618799745 pmcid: 30406678

El Sibai R, Bachir R, El Sayed M (2018) Outcomes in cardiogenic shock patients with extracorporeal membrane oxygenation use: a matched cohort study in hospitals across the United States. Biomed Res Int 2018:2428648. https://doi.org/10.1155/2018/2428648

doi: 10.1155/2018/2428648 pubmed: 29789779 pmcid: 5896328

Blumenstein J, Leick J, Liebetrau C, Kempfert J, Gaede L, Gross S, Krug M, Berkowitsch A, Nef H, Rolf A, Arlt M, Walther T, Hamm CW, Mollmann H (2016) Extracorporeal life support in cardiovascular patients with observed refractory in-hospital cardiac arrest is associated with favourable short and long-term outcomes: a propensity-matched analysis. Eur Heart J Acute Cardiovasc Care 5(7):13–22

pubmed: 26503919 doi: 10.1177/2048872615612454

Lin JW, Wang MJ, Yu HY, Wang CH, Chang WT, Jerng JS, Huang SC, Chou NK, Chi NH, Ko WJ, Wang YC, Wang SS, Hwang JJ, Lin FY, Chen YS (2010) Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: propensity analysis of three-year data. Resuscitation 81(7):796–803

pubmed: 20413202 doi: 10.1016/j.resuscitation.2010.03.002

Shin TG, Choi JH, Jo IJ, Sim MS, Song HG, Jeong YK, Song YB, Hahn JY, Choi SH, Gwon HC, Jeon ES, Sung K, Kim WS, Lee YT (2011) Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: a comparison with conventional cardiopulmonary resuscitation. Crit Care Med 39(1):1–7

pubmed: 21057309 doi: 10.1097/CCM.0b013e3181feb339

Shin TG, Jo IJ, Sim MS, Song YB, Yang JH, Hahn JY, Choi SH, Gwon HC, Jeon ES, Sung K, Lee YT, Choi JH (2013) Two-year survival and neurological outcome of in-hospital cardiac arrest patients rescued by extracorporeal cardiopulmonary resuscitation. Int J Cardiol 168(4):3424–3430

pubmed: 23664696 doi: 10.1016/j.ijcard.2013.04.183

Choi DS, Kim T, Ro YS, Ahn KO, Lee EJ, Hwang SS, Song SW, Song KJ, Shin SD (2016) Extracorporeal life support and survival after out-of-hospital cardiac arrest in a nationwide registry: A propensity score-matched analysis. Resuscitation 99:26–32

pubmed: 26683472 doi: 10.1016/j.resuscitation.2015.11.013

Maekawa K, Tanno K, Hase M, Mori K, Asai Y (2013) Extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest of cardiac origin: a propensity-matched study and predictor analysis. Crit Care Med 41(5):1186–1196

pubmed: 23388518 doi: 10.1097/CCM.0b013e31827ca4c8

Kim SJ, Jung JS, Park JH, Park JS, Hong YS, Lee SW (2014) An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study. Crit Care 18(5):535

pubmed: 25255842 pmcid: 4189722 doi: 10.1186/s13054-014-0535-8

Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, Saulnier F, Daubin C (2012) A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 83(11):1413–1417

pubmed: 22469751 doi: 10.1016/j.resuscitation.2012.03.028

Chang CH, Chen HC, Caffrey JL, Hsu J, Lin JW, Lai MS, Chen YS (2016) Survival analysis after extracorporeal membrane oxygenation in critically ill adults: a nationwide cohort study. Circulation 133(24):2423–2433

pubmed: 27199466 doi: 10.1161/CIRCULATIONAHA.115.019143 pmcid: 27199466

Lorusso R, Gelsomino S, Parise O, Mendiratta P, Prodhan P, Rycus P, MacLaren G, Brogan TV, Chen YS, Maessen J, Hou X, Thiagarajan RR (2017) Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock in elderly patients: trends in application and outcome from the Extracorporeal life support organization (ELSO) registry. Ann Thorac Surg 104(1):62–69

pubmed: 28131429 doi: 10.1016/j.athoracsur.2016.10.023 pmcid: 28131429

Richardson AS, Schmidt M, Bailey M, Pellegrino VA, Rycus PT, Pilcher DV (2017) ECMO Cardio-pulmonary resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years. Resuscitation 112:34–40

pubmed: 27993632 doi: 10.1016/j.resuscitation.2016.12.009 pmcid: 27993632

Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, Brodie D, Pellegrino V, Pilcher D (2015) Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 36(33):2246–2256

pubmed: 26033984 doi: 10.1093/eurheartj/ehv194 pmcid: 26033984

Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, Annich GM (2015) Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 191(8):894–901

pubmed: 25695688 pmcid: 4435456 doi: 10.1164/rccm.201409-1634OC

Huesch MD (2018) Volume-outcome relationships in extracorporeal membrane oxygenation: retrospective analysis of administrative data from Pennsylvania, 2007–2015. ASAIO J 64(4):450–457

pubmed: 29076948 doi: 10.1097/MAT.0000000000000675 pmcid: 29076948

Abrams D, Garan AR, Abdelbary A, Bacchetta M, Bartlett RH, Beck J, Belohlavek J, Chen YS, Fan E, Ferguson ND, Fowles JA, Fraser J, Gong M, Hassan IF, Hodgson C, Hou X, Hryniewicz K, Ichiba S, Jakobleff WA, Lorusso R, MacLaren G, McGuinness S, Mueller T, Park PK, Peek G, Pellegrino V, Price S, Rosenzweig EB, Sakamoto T, Salazar L, Schmidt M, Slutsky AS, Spaulding C, Takayama H, Takeda K, Vuylsteke A, Combes A, Brodie D, International EN, Extracorporeal Life Support TO (2018) Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med 44(6):717–729

pubmed: 29450594 doi: 10.1007/s00134-018-5064-5 pmcid: 29450594

Combes A, Brodie D, Bartlett R, Brochard L, Brower R, Conrad S, De Backer D, Fan E, Ferguson N, Fortenberry J, Fraser J, Gattinoni L, Lynch W, MacLaren G, Mercat A, Mueller T, Ogino M, Peek G, Pellegrino V, Pesenti A, Ranieri M, Slutsky A, Vuylsteke A, International EN (2014) Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 190(5):488–496

pubmed: 25062496 doi: 10.1164/rccm.201404-0630CP pmcid: 25062496

Annabi N, Yue K, Tamayol A, Khademhosseini A (2015) Elastic sealants for surgical applications. Eur J Pharm Biopharm 95(Pt A):27–39

pubmed: 26079524 pmcid: 4591192 doi: 10.1016/j.ejpb.2015.05.022

Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P (2013) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 34(2):112–120

pubmed: 22513777 doi: 10.1093/eurheartj/ehs081

Barrett CS, Jaggers JJ, Cook EF, Graham DA, Yarlagadda VV, Teele SA, Almond CS, Bratton SL, Seeger JD, Dalton HJ, Rycus PT, Laussen PC, Thiagarajan RR (2013) Pediatric ECMO outcomes: comparison of centrifugal versus roller blood pumps using propensity score matching. ASAIO J 59(2):145–151

pubmed: 23438777 doi: 10.1097/MAT.0b013e31828387cd

Byrnes J, McKamie W, Swearingen C, Prodhan P, Bhutta A, Jaquiss R, Imamura M, Fiser R (2011) Hemolysis during cardiac extracorporeal membrane oxygenation: a case-control comparison of roller pumps and centrifugal pumps in a pediatric population. ASAIO J 57(5):456–461

pubmed: 21822124 doi: 10.1097/MAT.0b013e31822e2475

Beckmann A, Benk C, Beyersdorf F, Haimerl G, Merkle F, Mestres C, Pepper J, Wahba A, Group EW (2011) Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg 40(3):676–680

pubmed: 21683610

Pichler P, Antretter H, Dunser M, Eschertzhuber S, Gottardi R, Heinz G, Polzl G, Pretsch I, Rajek A, Wasler A, Zimpfer D, Geppert A (2015) Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology. Med Klin Intensivmed Notfmed 110(6):407–420

pubmed: 26223445 doi: 10.1007/s00063-015-0052-9

Extracorporeal Life Support Organization (ELSO) guidelines for adult cardiac failure 2014. https://www.elso.org/Portals/0/IGD/Archive/FileManager/e76ef78eabcusersshyerdocumentselsoguidelinesforadultcardiacfailure1.3.pdf . Zugegriffen: 25. Aug. 2021

Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P, Extracorporeal Life Support Organization Task Force on Infections EMO. (2011) Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 12(3):277–281

pubmed: 20495508 doi: 10.1097/PCC.0b013e3181e28894

Vogel AM, Lew DF, Kao LS, Lally KP (2011) Defining risk for infectious complications on extracorporeal life support. J Pediatr Surg 46(12):2260–2264

pubmed: 22152861 doi: 10.1016/j.jpedsurg.2011.09.013

Lorusso R, Barili F, Mauro MD, Gelsomino S, Parise O, Rycus PT, Maessen J, Mueller T, Muellenbach R, Belohlavek J, Peek G, Combes A, Frenckner B, Pesenti A, Thiagarajan RR (2016) In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation: results from the Extracorporeal life support organization registry. Crit Care Med 44(10):e964–e972

pubmed: 27340754 doi: 10.1097/CCM.0000000000001865

Dalton HJ, Garcia-Filion P, Holubkov R, Moler FW, Shanley T, Heidemann S, Meert K, Berg RA, Berger J, Carcillo J, Newth C, Harrison R, Doctor A, Rycus P, Dean JM, Jenkins T, Nicholson C (2015) Eunice Kennedy shriver national institute of child H, human development collaborative pediatric critical care research N. association of bleeding and thrombosis with outcome in extracorporeal life support. Pediatr Crit Care Med 16(2):167–174

pubmed: 25647124 pmcid: 4605822 doi: 10.1097/PCC.0000000000000317

Polito A, Barrett CS, Wypij D, Rycus PT, Netto R, Cogo PE, Thiagarajan RR (2013) Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med 39(9):1594–1601

pubmed: 23749154 doi: 10.1007/s00134-013-2985-x

Werho DK, Pasquali SK, Yu S, Donohue J, Annich GM, Thiagarajan RR, Hirsch-Romano JC, Gaies MG, Extracorporeal Life Support Organization (2015) Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry. Pediatr Crit Care Med 16(3):276–288

pubmed: 25651048 pmcid: 4668708 doi: 10.1097/PCC.0000000000000345

Werho DK, Pasquali SK, Yu S, Donohue J, Annich GM, Thiagarajan RR, Hirsch-Romano JC, Gaies M, Centers EM (2015) Epidemiology of stroke in pediatric cardiac surgical patients supported with extracorporeal membrane oxygenation. Ann Thorac Surg 100(5):1751–1757

pubmed: 26298170 pmcid: 4630110 doi: 10.1016/j.athoracsur.2015.06.020

Wightman A, Bradford MC, Symons J, Brogan TV (2015) Impact of kidney disease on survival in neonatal extracorporeal life support. Pediatr Crit Care Med 16(6):576–582

pubmed: 25828782 pmcid: 5015680 doi: 10.1097/PCC.0000000000000414

Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Mullerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D (2017) Concomitant implantation of Impella((R)) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 19(3):404–412

pubmed: 27709750 doi: 10.1002/ejhf.668 pmcid: 27709750

Schmack B, Seppelt P, Weymann A, Alt C, Farag M, Arif R, Doesch AO, Raake PW, Kallenbach K, Mansur A, Popov AF, Karck M, Ruhparwar A (2017) Extracorporeal life support with left ventricular decompression-improved survival in severe cardiogenic shock: results from a retrospective study. PeerJ 5:e3813

pubmed: 28975053 pmcid: 5624302 doi: 10.7717/peerj.3813

Patel SM, Lipinski J, Al-Kindi SG, Patel T, Saric P, Li J, Nadeem F, Ladas T, Alaiti A, Phillips A, Medalion B, Deo S, Elgudin Y, Costa MA, Osman MN, Attizzani GF, Oliveira GH, Sareyyupoglu B, Bezerra HG (2019) Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory Cardiogenic shock. ASAIO J 65(1):21–28

pubmed: 29489461 doi: 10.1097/MAT.0000000000000767 pmcid: 29489461

Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H (2017) Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry. Crit Care 21(1):45

pubmed: 28264702 pmcid: 5339999 doi: 10.1186/s13054-017-1633-1

(2015) Extracorporeal Life Support Organization (ELSO) ultrasound guidance for extra-corporeal membrane oxygenation. https://www.elso.org/Portals/0/Files/elso_Ultrasoundguideance_ecmogeneral_guidelines_May2015.pdf . Zugegriffen: 25. Aug. 2021

Distelmaier K, Roth C, Schrutka L, Binder C, Steinlechner B, Heinz G, Lang IM, Maurer G, Koinig H, Niessner A, Hulsmann M, Speidl W, Goliasch G (2016) Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery. Br J Anaesth 117(1):52–58

pubmed: 27317704 pmcid: 4913403 doi: 10.1093/bja/aew151

Aso S, Matsui H, Fushimi K, Yasunaga H (2016) The effect of Intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med 44(11):1974–1979

pubmed: 27322361 doi: 10.1097/CCM.0000000000001828 pmcid: 27322361

Brechot N, Demondion P, Santi F, Lebreton G, Pham T, Dalakidis A, Gambotti L, Luyt CE, Schmidt M, Hekimian G, Cluzel P, Chastre J, Leprince P, Combes A (2018) Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care 7(1):62–69

pubmed: 28574276 doi: 10.1177/2048872617711169 pmcid: 28574276

Lin LY, Liao CW, Wang CH, Chi NH, Yu HY, Chou NK, Hwang JJ, Lin JL, Chiang FT, Chen YS (2016) Effects of additional intra-aortic balloon counter-pulsation therapy to cardiogenic shock patients supported by extra-corporeal membranous oxygenation. Sci Rep 6:23838

pubmed: 27032984 pmcid: 4817114 doi: 10.1038/srep23838

Park TK, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Sung K, Lee YT, Gwon HC (2014) Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock. BMC Anesthesiol 14:27

pubmed: 24725532 pmcid: 4003289 doi: 10.1186/1471-2253-14-27

Ro SK, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW (2014) Extracorporeal life support for cardiogenic shock: influence of concomitant intra-aortic balloon counterpulsation. Eur J Cardiothorac Surg 46(2):186–192 (discussion 192)

pubmed: 24510911 doi: 10.1093/ejcts/ezu005 pmcid: 24510911

Cheng R, Ramzy D, Azarbal B, Arabia FA, Esmailian F, Czer LS, Kobashigawa JA, Moriguchi JD (2017) Device strategies for patients in INTERMACS profiles 1 and 2 cardiogenic shock: double bridge with extracorporeal membrane oxygenation and initial implant of more durable devices. Artif Organs 41(3):224–232

pubmed: 27658844 doi: 10.1111/aor.12758 pmcid: 27658844

Fukuhara S, Takeda K, Kurlansky PA, Naka Y, Takayama H (2018) Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults. J Thorac Cardiovasc Surg 155(4):1607–1618e6

pubmed: 29361299 doi: 10.1016/j.jtcvs.2017.10.152

Davidson JE, Aslakson RA, Long AC, Puntillo KA, Kross EK, Hart J, Cox CE, Wunsch H, Wickline MA, Nunnally ME, Netzer G, Kentish-Barnes N, Sprung CL, Hartog CS, Coombs M, Gerritsen RT, Hopkins RO, Franck LS, Skrobik Y, Kon AA, Scruth EA, Harvey MA, Lewis-Newby M, White DB, Swoboda SM, Cooke CR, Levy MM, Azoulay E, Curtis JR (2017) Guidelines for family-centered care in the neonatal, pediatric, and adult ICU. Crit Care Med 45(1):103–128

pubmed: 27984278 doi: 10.1097/CCM.0000000000002169

White DB, Angus DC, Shields AM, Buddadhumaruk P, Pidro C, Paner C, Chaitin E, Chang CH, Pike F, Weissfeld L, Kahn JM, Darby JM, Kowinsky A, Martin S, Arnold RM, Investigators PA (2018) Randomized Trial of a Family-Support Intervention in Intensive Care Units. N Engl J Med 378(25):2365–2375

pubmed: 29791247 doi: 10.1056/NEJMoa1802637

Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztebl Int 108(7):346–348

Neitzke G, Burchardi H, Duttge G, Hartog C, Erchinger R, Gretenkort P, Michalsen A, Mohr M, Nauck F, Salomon F, Stopfkuchen H, Weiler N, Janssens U (2016) Limits of the meaningfulness of intensive care medicine : position paper of the ethics section of DIVI. Med Klin Intensivmed Notfmed 111(6):486–492

pubmed: 27457820 doi: 10.1007/s00063-016-0202-8